https://www.selleckchem.com/pr....oducts/Erlotinib-Hyd
44; p [corrected] = .035) and mediated the negative effect of disease burden on processing speed (indirect path std. beta = -.20, p = .047; direct path std. beta = -.19, p = .25; total effect std. beta = -.39, p = .02). The corresponding analyses in sporadic SVD showed no effect. Intraclass correlations in the high-frequency serial MRI dataset of the sporadic SVD patients revealed poor test-retest reliability and analysis of individual variability suggested an influence of age, but not disease burden, on global efficienc
Like
Comment
Share
